Form 8-K Filing: ENvue Medical, Inc. Announces Executive Employment and Consulting Agreements

ENvue Medical, Inc. has filed a Form 8-K detailing significant changes in its executive and financial leadership. The company entered into an amended and restated employment agreement with Doron Besser, M.D., the Chief Executive Officer. Effective December 17, 2025, the agreement provides Dr. Besser with an annual salary of $360,000 and a potential annual bonus of up to $180,000, contingent on performance. The agreement also includes provisions for termination, including severance pay equivalent to 12 months' base salary under specific conditions such as termination without cause or resignation for good reason, especially in the event of a Change in Control. Furthermore, Dr. Besser will be granted 180,000 restricted stock units, representing 9% of the company's fully diluted common stock, and will participate in a study fund with company contributions. Concurrently, Stephen Brown has ceased to be the Chief Financial Officer, and Nicole Fernandez-McGovern has been appointed as the Interim Chief Financial Officer through a consulting agreement with RCM Financial Consulting, Inc., effective December 18, 2025. Ms. Fernandez-McGovern brings over 25 years of financial executive experience. Her consulting agreement stipulates an annual salary of $300,000 and outlines her responsibilities, including financial statement accuracy and impairment testing. The filing also lists the exhibits, including the full employment and consulting agreements.